Beyond lithium in the treatment of bipolar illness

Neuropsychopharmacology

Volumn 19, Issue 3, 1998, Pages 206-219

  Post, Robert M ^a   Frye, Mark A ^a   Denicoff, Kirk D ^a   Leverich, Gabriele S ^a   Kimbrell, Tim A ^a   Dunn, Robert T ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Calcium channel blockers; Carbamazepine; Gabapentin; Lamotrigine; rTMS; Valproate

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLONAZEPAM; CLOZAPINE; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; FLUNARIZINE; GABAPENTIN; ISRADIPINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; NIFEDIPINE; NIMODIPINE; OLANZAPINE; OXCARBAZEPINE; PENICILLIN G; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROATE CALCIUM; VALPROIC ACID; VERAPAMIL;

BIPOLAR DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0032171374     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00020-7     Document Type: Article

References (144)

1. Aagaard J., Vestergaard P. Predictors of outcome in prophylactic lithium treatment. A 2-year prospective study J Aff Dis. 18:1990;259-266.
2. Ballenger J.C., Post R.M. Therapeutic effects of carbamazepine in affective illness. Preliminary report Commun Psychopharmacol. 2:1978;159-175.
3. Ban T.A., Morey L., Aguglia E., Azzarelli O., Balsano F., Marigliano V., Caglieris N., Sterlicchio M., Capurso A., Tomasi N.A. Nimodipine in the treatment of old age dementias. Prog Neuropsychopharmacol Biol Psych. 14:1990;525-551.
4. Barton B.M., Gitlin M.J. Verapamil in treatment-resistant mania. An open trial J Clin Psychopharmacol. 7:1987;101-103.
5. Bellaire W., Demisch K., Stoll K.-D. Carbamazepine vs. Lithium. Application in the Prophylaxis of Recurrent Affective and Schizoaffective Psychoses. Munch Med Wschr. 132:1990;S82-S86.
6. Beydoun A., Uthman B.M., Sackellares J.C. Gabapentin. Pharmacokinetics, efficacy, and safety Clin Neuropharm. 18:1995;469-481.
7. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., Garza-Trevino E.S., Risch S.C., Goodnick P.J., Morris D.D. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA. 271:1994;918-924.
8. Bowden C.L., Janicak P.G., Orsulak P., Swann A.C., Davis J.M., Calabrese J.R., Goodnick P., Small J.G., Rush A.J., Kimmel S.E., Risch S.C., Morris D.D. Relation of serum valproate concentration to response in mania. Am J Psychiat. 153:1996;765-770.
9. Bradwejn J., Shriqui C., Koszycki D., Meterissian G. Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol. 10:1990;403-408.
10. Brodie M.J., Richens A., Yuen A.W. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet. 345:1995;476-479.
11. Brotman A.W., Farhadi A.M., Gelenberg A.J. Verapamil treatment of acute mania. J Clin Psychiat. 47:1986;136-138.
12. Brown D., Silverstone T., Cookson J. Carbamazepine compared to haloperidol in acute mania. Int Clni Psychopharmacol. 4:1989;229-238.
13. Brunet G., Cerlich B., Robert P., Dumas S., Souetre E., Darcourt G. Open trial of a calcium antagonist, nimodipine in acute mania. Clin Neuropharmacol. 13:1990;224-228.
14. Busch F.N., Miller F.T., Weiden P.J. A comparison of two adjunctive treatment strategies in acute mania. J Clin Psychiat. 50:1989;453-455.
15. Cabrera J.F., Muhlbauer H.D., Schley J., Stoll K.D., Muller-Oerlinghausen B. Long-term randomized clinical trial on oxcarbazepine vs. lithium in bipolar and schizoaffective disorders. Preliminary results Pharmacopsychiatry. 19:1986;282-283.
16. Caillard V. Treatment of mania using a calcium antagonist - Preliminary trial. Neuropsychobiology. 14:1985;23-26.
17. Calabrese J.R., Delucchi G.A. Phenomenology of rapid cycling manic depression and its treatment with valproate. J Clin Psychiat. 50:1989;30-34.
18. Calabrese J.R., Delucchi G.A. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiat. 147:1990;431-434.
19. Calabrese J.R., Markovitz P.J., Kimmel S.E., Wagner S.C. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol. 12:1992;53S-56S.
20. Calabrese J.R., Woyshville M.J. A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry. 56(Suppl 3):1995;11-18.
21. Calabrese C. Lamotrigine in treatment refractory manic depression. J Eur College Neuropsychopharmacology. 6:1996;98.
22. Calabrese J.R., Kimmel S.E., Woyshville M.J., Rapport D.J., Faust C.J., Thompson P.A., Meltzer H.Y. Clozapine for treatment-refractory mania. Am J Psychiat. 153:1996;759-764.
23. Catalá M.D., Rubio B., Pascual-Leone A. Lateralized effect of rapid-rate transcranial magnetic stimulation of dorsolateral prefrontal cortex on depression. Neurology. 46:1996;A327-A328. 005).
24. Chouinard G., Young S.N., Annable L. Antimanic effect of clonazapam. Biol Psychiat. 18:1983;451-466.
25. Chouinard G., Annable L., Turnier L., Holobow N., Szkrumelak N. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. Can J Psychiat. 38:1993;S114-S121.
26. Coxhead N., Silverstone T., Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiat Scand. 85:1992;114-118.
27. Deicken R.F. Verapamil treatment of bipolar depression. J Clin Psychopharmacol. 10:1990;148-149.
28. Denicoff K.D., Smith-Jackson E.E., Disney E.R., Ali S.O., Leverich G.S., Post R.M. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry. 58:1997;470-478.
29. Denney D., Stevens J.R. Clozapine and seizures. Biol Psychiat. 37:1995;427-433.
30. Desai NG, Gangadhar BN, Channabasavanna SM, Shetty KT (1987): Carbamazepine hastens therapeutic action of lithium in mania. Proceedings of the International Conference on New Directions in Affective Disorders, 97.
31. Di Costanzo E., Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiat Scand. 83:1991;456-459.
32. Dose M., Emrich H.M., Cording-Tommel C., Von Zerssen D. Use of calcium antagonists in mania. Psychoneuroendocrinology. 11:1986;241-243.
33. Dubovsky S.L., Franks R.D., Lifschitz M., Coen P. Effectiveness of verapamil in the treatment of a manic patient. Am J Psychiat. 139:1982;502-504.
34. Dubovsky S.L., Franks R.D. Intracellular calcium in affective disorders. A review and an hypothesis Biol Psychiat. 18:1983;781-797.
35. Dubovsky S., Franks R., Schrier D. Phenelzine-induced hypomania. Effect of verapamil Biol Psychiat. 20:1985;1009-1014.
36. Dubovsky S.L., Franks R.D., Allen S. Calcium antagonists in mania. A double-blind study of verapamil Psychiat Res. 18:1986;309-320.
37. Dubovsky S.L., Franks R.D. Verapamil. A new antimanic drug with potential interactions with lithium J Clin Psychiat. 48:1987;371-372.
38. Eccleston D., Cole A.J. Calcium-channel blockade and depressive illness. Br J Psychiat. 156:1990;889-891.
39. Eckmann F. Clinical studies on nimodipine in the treatment of patients with depressive syndromes in the second half of life. Betz E., Deck K., Hoffmeister F. Nimodipine. Pharmacological and Clinical Studies:1985;307-313 Schattauer, Stuttgart. a.
40. Eckmann V.F. Double-blind clinical study with the calcium antagonist flunarizine in cerebral circulatory disturbances. Arzneimittelforschung. 35:1985;1276-1279. b.
41. Edwards R., Stephenson U., Flewett T. Clonazepam in acute mania. A double-blind trial Aust N Z J Psychiat. 25:1991;238-242.
42. Elphick M., Lyons F., Cowen P.J. Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness. J Psychopharmacol. 2:1988;1-4.
43. Emrich H.M., Dose M., Von Zerssen D. Action of sodium-valproate and of oxcarbazepine in patients with affective disorders. Emrich H.M., Okuma T., Muller A.A. Anticonvulsants in Affective Disorders. 1984;45-55 Excerpta Medica, Amsterdam.
44. Emrich H.M., Dose M., Von Zerssen D. The use of sodium valproate, carbamazepine, and oxcarbazepine in patients with affective disorders. J Aff Dis. 8:1985;243-250.
45. Emrich H.M. Studies with oxcarbazepine (Trileptal) in acute mania. Int Clin Psychopharmacol. 5:1990;83-88.
46. Fawcett J (1988): Personal Communication, March.
47. Frankenburg F.R., Tohen M., Cohen B.M., Lipinski J.F. Jr. Long-term response to carbamazepine. A retrospective study J Clin Psychopharmacol. 8:1988;130-132.
48. Freedman D.D., Waters D.D. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications. Drugs. 34:1987;578-598.
49. Fromm G.H., Terrence C.F. Effects of antiepileptic drugs on the brain-stem. Fromm G.H., Faingold C.L., Browning R.A., Burnham W.M. Epilepsy and the Reticular Formation. 1987;119-136 Alan R. Liss, New York.
50. Frye MA (1996): The increasing use of polypharmacy for refractory mood disorders: Twenty-five years of study (abstract). APA New Research Program and Abstracts, pp 151-152 (abstract NR312).
51. Frye M.A., Altshuler L.L., Bitran J. Clozapine in rapid cycling bipolar disorder. J Clin Psychopharmacol. 16:1996;87-90.
52. Frye M.A., Ketter T.A., Kimbrell T.A., Dunn R.M., Speer A.M., Osuch E.A., Luckenbaugh D., Cora-Locatelli G., Leverich G.S., Post R.M. Gabapentin and lamotrigine monotherapy in mood disorder (abstract). Syllabus and Proceedings Summary of the. 151st(Meeting of the American Psychiatric Association in press):1998.
53. Garza-Trevino ES (1990): Verapamil versus lithium in acute mania. Abstracts of the 143rd Annual Meeting of the American Psychiatric Association: 78 (abstract #27).
54. Garza-Trevino E.S., Overall J.E., Hollister L.E. Verapamil versus lithium in acute mania. Am J Psychiat. 149:1992;121-122.
55. Gelenberg A.J., Kane J.M., Keller M.B., Lavori P., Rosenbaum J.F., Cole K., Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 321:1989;1489-1493.
56. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., Hallett M., Post R.M. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. NeuroReport. 6:1995;1853-1856.
57. George MS, Wassermann EM, Williams WA, Kimbrell TA, Little JT, Hallett M, Post RM (1996): Daily left prefrontal repetitive transcranial magnetic stimulation in outpatient depression: Initial results of a double-blind placebo controlled crossover trial (abstract). APA New Research Program and Abstracts: 280 (abstract NR768).
58. George M.S., Wassermann E.M., Kimbrell T.A., Little J.T., Williams W.E., Danielson A.L., Greenberg B.D., Hallett M., Post R.M. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression. A placebo-controlled crossover trial Am J Psychiatry. 154:1997;1752-1756.
59. Giannini A.J., House W.L., Loiselle R.H. Antimanic effects of verapamil. Am J Psychiat. 141:1984;1602-1603.
60. Giannini A.J., Taraszewski R., Loiselle R.H. Verapamil and lithium in maintenance therapy of manic patients. J Clin Pharmacol. 27:1987;980-982.
61. Giannini AJ, Sullivan BS, Folts DJ (1989): Comaprison of lithium carbonate, valproic acid and verapamil in the treatment of manic symptoms. J Clin Pharmacol 29:832 (abstract #1).
62. Gitlin M.J., Weiss J. Verapamil as maintenance treatment in bipolar illness. a case report J Clin Psychopharmacol. 4:1984;341-343.
63. Gitlin M.J., Swendsen J., Heller T.L., Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiat. 152:1995;1635-1640.
64. Goncalves N., Stoll K.D. Carbamazepine in manic syndromes. A controlled double-blind study. Nervenarzt. 56:1985;43-47.
65. Goodnick P.J. Nimodipine treatment of rapid cycling bipolar disorder. J Clin Psychiat. 56:1995;330.
66. Graham S.R., Kokkinidis L. Clozapine inhibits limbic system kindling. Implications for antipsychotic action Brain Res Bull. 30:1993;597-605.
67. Greil W., Ludwig-Mayerhofer W., Erazo N., Schochlin C., Schmidt S., Engel R.R., Czernic A., Giedke H., Müller-Oerlinghausen B., Osterheider M., Rudolf G.A., Sauer H., Tegeler J., Wetterling T. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Affect Disord. 43:1997;151-161. a.
68. Greil W., Ludwig-Mayerhofer W., Erazo N., Engel R.R., Czernik A., Giedke H., Müller-Oerlinghausen B., Osterheider M., Rudolf G.A., Sauer H., Tegeler J., Wetterling T. Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder. A randomised study Eur Arch Psychiatry Clin Neurosci. 247:1997;42-50. b.
69. Grossi E., Sacchetti E., Vita A., Conte G., Faravelli C., Hautmann G., Zerbi D., Mesina A.M., Drago F., Motta A. Carbamazepine vs. chlorpromazine in mania. A double-blind trial Emrich H.M., Okuma T., Muller A.A. Anticonvulsants in Affective Disorders. 1984;177-187 Excerpta Medica, Amsterdam.
70. Grunze H., Walden J., Wolf R., Berger M. Combined treatment with lithium and nimodipine in a bipolar I manic syndrome. Prog Neuropsychopharmacol Biol Psychiat. 20:1996;419-426.
71. Hoschl C. Verapamil for depression? Am J Psychiat. 140:1983;1100.
72. Hoschl C., Kozeny J. Verapamil in affective disorders. A controlled, double-blind study Biol Psychiat. 25:1989;128-140.
73. Hoschl C., Vackova J., Janda B. Mood stabilizing effect of verapamil. Bratisl Lek Listy. 93:1992;208-209.
74. Hunt N., Silverstone T. Tardive dyskinesia in bipolar affective disorder. A catchment area study Int Clin Psychopharmacol. 6:1991;45-50.
75. Hyman S.E., Arana G.W. Handbook of Psychiatric Drug Therapy. 1987;Little Brown, Boston.
76. Janicak PG, Pandey G, Sharma R, Peterson J, Leach A, Davis JM (1994): Verapamil for actue mania: Preliminary results from a double-blind, placebo-controlled study (abstract). Proceedings of 1st International Conference on Bipolar Disorder, 46.
77. Keck P.E. Jr., McElroy S.L., Tugrul K.C., Bennett J.A. Valproate oral loading in the treatment of acute mania. J Clin Psychiat. 54:1993;305-308.
78. Ketter TA, Kimbrell TA, George MS, Stein RM, Willis MW, Benson BE, Frye MA, Cora-Locatelli G, Post RM (1996): Baseline hypermetabolism may predict carbamazepine response and hypometabolism nimodipine response in mood disorders. Abstracts of the XXth Collegium Internationale Neuro-Psychopharmacologicum Congress:10 (abstract #O-5-6).
79. Kishimoto A., Okuma T. Antimanic and prophylactic effects of carbamazepine in affective disorders. Shagass C., Josiassen R.C., Bridger W.H., Weiss K.J., Stoff D., Simpson G.M. Biological Psychiatry 1985. 1986;883-885 Elsevier, Amsterdam.
80. Klein E., Bental E., Lerer B., Belmaker R.H. Carbamazepine and haloperidol vs. placebo and haloperidol in excited psychoses. Arch Gen Psychiat. 41:1984;165-170.
81. Koukopoulos A., Reginaldi D., Minnai G., Serra G., Pani L., Johnson F.N. The long-term prophylaxis of affective disorders. Adv Biochem Psychopharmacol. 49:1995;127-147.
82. Lambert P.A. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). Emrich H.M., Okuma T., Muller A.A. Anticonvulsants in Affective Disorders. 1984;33-44 Excerpta Medica, Amsterdam.
83. Lambert P.A., Venaud G. Comparative study of valpromide vs.lithiumas prophylactic treatments in affective disorders. Nervure J Psychiatrie. 1-9:1995.
84. Lenox R.H., Newhouse P.A., Creelman W.L., Whitaker T.M. Adjunctive treatment of manic agitation with lorazepam versus haloperidol. A double-blind study J Clin Psychiat. 53:1992;47-52.
85. Lenzi A., Lazzerini F., Grossi E., Massimetti G., Placidi G.F. Use of carbamazepine in acute psychosis. A controlled study J Int Med Res. 14:1986;78-84.
86. Lerer B., Moore N., Meyendorff E., Cho S.R., Gershon S. Carbamazepine versus lithium in mania. A double-blind study J Clin Psychiat. 48:1987;89-93.
87. Lindelius R., Nilsson C.G. Flunarizine as maintenance treatment of a patient with bipolar disorder. Am J Psychiat. 149:1992;139.
88. Lusznat R.M., Murphy D.P., Nunn C.M. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br J Psychiat. 153:1988;198-204.
89. Maj M., Pirozzi R., Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology (Berlin). 98:1989;535-538.
90. Manna V. Bipolar affective disorders and role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and/or calcium antagonist in patients with rapid polar inversion. Minerva Med. 82:1991;757-763.
91. McDermut W., Pazzaglia P.J., Huggins T., Mikalauskas K., Leverich G.S., Ketter T.A., Bartko J., Post R.M. Use of single case analyses in off-on-off-on trials in affective illness. A demonstration of the efficacy of nimodipine Depression. 2:1995;259-271.
92. Messenheimer J.A. Lamotrigine. Epilepsia. 36:1995;S87-S94.
93. Moller H.J., Kissling W., Riehl T., Bauml J., Binz U., Wendt G. Double-blind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol. Prog Neuropsychopharmacol Biol Psychiat. 13:1989;127-136.
94. Montenegro R., Comide E., Castro J.M. Nimodipine in the treatment of involutional depressive syndrome. Betz E., Deck K., Hoffmeister F. Nimodipine. Pharmacological and Clinical Studies:1985;307-313 Schattauer, Stuttgart.
95. Mosolov S.N. Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses. Zh Nevropatol Psikhiatr. 91:1991;78-83.
96. Muller A.A., Stoll K.-D. Carbamazepine and oxcarbamazepine in the treatment of manic syndromes. studies in Germany Emrich H.M., Okuma T., Muller A.A. Anticonvulsants in Affective Disorders. 1984;139-147 Excerpta Medica, Amsterdam.
97. O'Connell R.A., Mayo J.A., Flatow L., Cuthbertson B., O'Brien B.E. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiat. 159:1991;123-129.
98. Okuma T., Inanaga K., Otsuki S., Sarai K. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine. A double-blind controlled study Psychopharmacology. 66:1979;211-217.
99. Okuma T., Inanaga K., Otsuki S., Sarai K., Takahashi R., Hazama H., Mori A., Watanabe M. A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology. 73:1981;95-96.
100. Okuma T., Yamashita I., Takahashi R., Itoh H., Kurihara M., Otsuki S., Watanabe S., Sarai K., Hazama H., Inangana K. Double-blind controlled studies on the therapeutic efficacy of carbamazepine in affective and schizophrenic patients. Psychopharmacology. 96:1988;102-118. 05).
101. Okuma T., Yamashita I., Takahashi R., Itoh H., Otsuki S., Watanabe S., Sarai K., Hazama H., Inananga K. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry. 23:1990;143-150.
102. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology. 27:1993;138-145.
103. Pani L., Kuzmin A., Diana M., De Montis G., Gessa G.L., Rossetti Z.L. Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol. 190:1990;217-221.
104. Pascual-Leone A., Rubio B., Pallardo F., Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348:1996;233-237.
105. Patterson J.F. Treatment of acute mania with verapamil. J Clin Psychopharmacol. 7:1987;206-207.
106. Pazzaglia P.J., Post R.M. Contingent tolerance and reresponse to carbamazepine. A case study in a patient with trigeminal neuralgia and bipolar disorder J Neuropsychiat Clin Neurosci. 4:1992;76-81.
107. Pazzaglia P.J., Post R.M., Ketter T.A., George M.S., Marangell L.B. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiat Res. 49:1993;257-272.
108. Pazzaglia P.J., Post R.M., Ketter T.A., Callahan A.M., Marangell L.B., Frye M.A., George M.S., Kimbrell T.A., Leverich G.S., Cora-Locatelli G., Luckenbaugh D. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol. in press:1998.
109. Placidi G.F., Lenzi A., Lazzerini F., Cassano G.B., Akiskal H.S. The comparative efficacy and safety of carbamazepine versus lithium. A randomized, double-blind 3-year trial in 83 patients J Clin Psychiat. 47:1986;490-494.
110. Pollack M.H., Rosenbaum J.F. Verapamil in the treatment of recurrent unipolar depression. Biol Psychiat. 22:1987;779-782.
111. Pope H.G., McElroy S.L., Keck P.E. Jr., Hudson J.I. Valproate in the treatment of acute mania. Arch Gen Psychiat. 48:1991;62-68.
112. Post R.M., Uhde T.W., Ballenger J.C., Squillace K.M. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiat. 140:1983;1602-1604.
113. Post R.M., Ballenger J.C., Uhde T.W., Bunney W.E.J. Efficacy of carbamazepine in manic-depressive illness. Implications for underlying mechanisms Post R.M., Ballenger J.C. Neurobiology of Mood Disorders. 1984;777-816 Williams & Wilkins, Baltimore. a.
114. Post R.M., Berrettini W.H., Uhde T.W., Kellner C.H. Selective response to the anticonvulsant carbamazepine in manic-depressive illness. A case study J Clin Psychopharmacol. 4:1984;178-185. b.
115. Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. Antidepressant effects of carbamazepine. Am J Psychiat. 143:1986;29-34.
116. Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. Correlates of antimanic response to carbamazepine. Psychiat Res. 21:1987;71-83.
117. Post R.M. Use of anticonvulsants in the treatment of manic-depressive illness. Post R.M., Trimble M.R., Pippenger C.E. Clinical Use of Anticonvulsants in Psychiatric Disorders. 1989;113-152 Demos Publications, New York.
118. Post R.M., Leverich G.S., Rosoff A.S., Altshuler L.L. Carbamazepine prophylaxis in refractory affective disorders. A focus on long-term follow-up J Clin Psychopharmacol. 10:1990;318-327.
119. Post R.M., Leverich G.S., Altshuler L., Mikalauskas K. Lithium discontinuation-induced refractoriness. Preliminary observations Am J Psychiat. 149:1992;1727-1729.
120. Post R.M., Leverich G.S., Pazzaglia P.J., Mikalauskas K., Denicoff K. Lithium tolerance and dicontinuation as pathways to refractoriness. Birch N.J., Padgham C., Hughes M.S. Lithium in Medicine and Biology. 1993;71-84 Marius Press, Lancashire, UK.
121. Post R.M., Ketter T.A., Pazzaglia P.J., Denicoff K., Marangell L., George M.S. Anticonvulsants in refractory mood disorders. Nolen W.A., Zohar J., Roose S.P. Refractory Depression. Current Strategies and Future Directions:1994;97-114 John Wiley & Sons, Chichester, England.
122. Post R.M., Ketter T.A., Denicoff K., Pazzaglia P.J., Leverich G.S., Marangell L.B., Callahan A.M., George M.S., Frye M.A. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berlin). 128:1996;115-129. a.
123. Post R.M., Ketter T.A., Pazzaglia P.J., Denicoff K., George M.S., Callahan A., Leverich G., Frye M. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res. 11(suppl):1996;153-180. b.
124. Post R.M., Denicoff K.D., Frye M.A., Leverich G.S. Algorithms for bipolar mania. Rush A.J. Mood Disorders. Systematic Medication Management. 1997;114-145 Karger, Basel.
125. Prien R.F., Gelenberg A.J. Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiat. 146:1989;840-848.
126. Roy-Byrne P.P., Joffe R.T., Uhde T.W., Post R.M. Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications Arch Gen Psychiat. 41:1984;1150-1153.
127. Sarantidis D., Waters B. Predictors of lithium prophylaxis effectiveness. Prog Neuropsychopharmacol. 5:1981;507-510.
128. Schaff M.R., Fawcett J., Zajecka J.M. Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiat. 54:1993;380-384.
129. Sernyak M.J., Griffin R.A., Johnson R.M., Pearsall H.R., Wexler B.E., Woods S.W. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiat. 151:1994;133-135.
130. Small J.G., Klapper M.H., Milstein V., Kellams J.J., Miller M.J., Marhenke J.D., Small I.F. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiat. 48:1991;915-921.
131. Solomon I., Williamson P. Verapamil in bipolar illness. Can J Psychiat. 31:1986;442-444.
132. Stoll K.D., Bisson H.E., Fischer E., Gammel G., Goncalves N., Krober H.L., Muldner H., Nadler A., Troyke P. Carbamazepine versus haloperidol in manic syndromes - First report of a multicentric study in Germany. Shagass C., Josiassen R.C., Bridger W.H., Weiss K.J., Stoff D., Simpson G.M. Biological Psychiatry 1985. 1986;332-334 Elsevier, Amsterdam.
133. Suppes T., McElroy S.L., Gilbert J., Dessain E.C., Cole J.O. Clozapine in the treatment of dysphoric mania. Biol Psychiat. 32:1992;270-280.
134. Svestka J., Nahunek K., Ceskova E., Korbicka J. Carbamazepine prophylaxis of affective psychoses (intraindividual comparison with lithium carbonate). Activ Nerv Sup. 27:1985;261-262.
135. Tamminga C.A., Lahti A.C. The new generation of antipsychotic drugs. Int Clin Psychopharmacol. 11:1996;73-76.
136. Triggle D.J. Biochemical and pharmacologic differences among calcium channel antagonists. Clinical implications Epstein M. Calcium Antagonists in Clinical Medicine. 1992;1-27 Hanley & Belfus, Philadelphia.
137. Vestergaard P. Treatment and prevention of mania. A Scandinavian perspective Neuropsychopharmacology. 7:1992;249-260.
138. Walden J., Grunze H., Hellhammer D., Fritze J., Berger M. Treatment of depressive episodes with the calcium antagonist nimodipine. Single case reports Neuropsychopharmacology. 10:1994;233S.
139. Walton S.A., Berk M., Brook S. Superiority of lithium over verapamil in mania. A randomized conrolled trial J Eur College Neuropsychopharmacol. 6:1996;9-10.
140. Watkins S.E., Callender K., Thomas D.R., Tidmarsh S.F., Shaw D.M. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiat. 150:1987;180-182.
141. Weiss S.R.B., Clark M., Rosen J.B., Smith M.A., Post R.M. Contingent tolerance to the anticonvulsant effects of carbamazepine. Relationship to loss of endogenous adaptive mechanisms Brain Res Rev. 20:1995;305-325. a.
142. Weiss S.R.B., Li X.L., Rosen J.B., LiH Heynen T., Post R.M. Quenching. Inhibition of development and expression of amygdala kindled seizures with low frequency stimulation NeuroReport. 6:1995;2171-2176. b.
143. Wolf C., Berky M., Kovacs G. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorders. A randomised, double-blind 1-year study in 168 patients (abstract) Eur Neuropsychopharmacol. 7(suppl. 2):1997;S176.
144. Young L.T., Robb J.C., Patelis-Siotis I., MacDonald C., Joffe R.T. Acute treatment of bipolar depression with garapentin. Biol Psychiat. 42:1997;851-853.